If you’re interested in promoting clinical trials, please note that all postings and references to clinical trial recruitment must be approved by Einstein’s federally mandated Institutional Review Board (IRB).
Advertisements may be submitted as part of the new protocol or through the amendment form in iRIS.
IRB review of posts to ClinicalTrials.gov is not required. Einstein’s designated clinical trials Twitter feed is @EinsteinStudies. If you would like your study to be posted to the @EinsteinStudies account, please contact Eileen Shore of the Harold and Muriel Block Institute for Clinical and Translational Research (email@example.com) who will review your request and post the study on your behalf.